Status:
COMPLETED
Group Version of the UP-A in a Spanish Day Hospital for Adolescents.
Lead Sponsor:
Universidad Nacional de Educación a Distancia
Collaborating Sponsors:
Puerta de Hierro University Hospital
Conditions:
Anxiety Disorders
Depressive Disorder
Eligibility:
All Genders
11-18 years
Phase:
NA
Brief Summary
This study aims to adapt the Spanish version of the UP-A for group delivery in an intensive treatment setting for adolescents with severe mental disorders within a day hospital of the Spanish public h...
Detailed Description
Anxiety and depression are among the most prevalent mental health disorders in adolescents, often co-occurring due to shared transdiagnostic factors such as poor emotion regulation, high negative affe...
Eligibility Criteria
Inclusion
- Being an active patient at the Day Hospital of the Puerta de Hierro Hospital
- Presenting, as the main diagnosis (most serious diagnosis or the one that interferes the most), an emotional disorder with moderate or high severity including the following disorders based on DSM-5 categories: Depressive Disorders (Major Depressive Disorder and Persistent Depressive Disorder), Bipolar Disorders (Bipolar I and II Disorder, Cyclothymic Disorder), Anxiety Disorders (Specific Phobia, Panic Disorder, Agoraphobia, Social Anxiety Disorder, Generalized Anxiety Disorder), Obsessive-Compulsive and Related Disorders (including Body Dysmorphic Disorder, Hoarding Disorder, Trichotillomania and Excoriation (Skin-Picking) Disorder), Trauma and Stressor-Related Disorders (Reactive Attachment Disorder, Post-Traumatic Stress Disorder, Acute Stress Disorder and Adjustment Disorders), Dissociative Disorders (Dissociative Identity Disorder, Depersonalization/Derealization Disorder) and Somatic Symptom and Related Disorders (Somatic Symptom Disorder and Illness Anxiety Disorder). Specified and unspecified disorders from the above categories are also included.
- Being able to participate normally in group therapy (despite presenting self-harm or suicidal ideation, severe depressive disorder or dysfunctional personality and/or autism spectrum disorder)
- Being 11-18 years of age
- Being proficient in Spanish
- Being able to attend the evaluation and treatment sessions
- At least one of the adolescent's parents or legal guardians being able to complete the evaluation questionnaires
- If the participant was taking psychiatric medication, the dose being remaining stable for at least 1 month before the start of treatment and throughout it
Exclusion
- Presenting one or more of the following clinical conditions (either as a main or comorbid diagnosis): 1) Intellectual Disability, 2) Autism Spectrum Disorder accompanied by an intellectual disability that does not allow for group therapeutic work, 3) Disruptive, Impulse-Control and Conduct Disorders with a severity level that hinders group work, 4) Eating Disorders as the main diagnosis, 5) Psychotic Spectrum Disorders or psychotic-type symptoms, 6) Substance Abuse Disorders (excluding cannabis, coffee and/or nicotine) as the main diagnosis
- The characteristics or severity of the symptoms presented by the adolescent requiring an individual intervention or one adapted to the specific clinical condition
- Suffering from a serious medical illness that makes the adolescent's participation in the treatment program unsustainable
- The participant, or, if under 16 years of age, his or her parents, having refused to sign the informed consent
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06894394
Start Date
January 1 2023
End Date
July 30 2025
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Día Infantojuvenil del Hospital Puerta de Hierro de Majadahonda
Madrid, Madrid, Spain, 28222